New Drug Prevents Recurrence of Congenital Heart Block in Pregnant Women at High Risk#USA#New_York#rozanolixizumab#congenital_heart_block#NHU_Langone
New Drug Prevents Recurrence of Congenital Heart Block in Pregnant Women at High Risk
A groundbreaking study reveals how the drug rozanolixizumab can effectively prevent congenital heart block in high-risk pregnancies, promising safer outcomes for affected infants.
third-news.com
October 22, 2025 at 9:22 AM
New Drug Prevents Recurrence of Congenital Heart Block in Pregnant Women at High Risk#USA#New_York#rozanolixizumab#congenital_heart_block#NHU_Langone